Oslo, Norway headquartered Nattopharma has announced that it has been selected by Ortho Molecular Products, a leader in practitioner-specific nutraceuticals, as its exclusive Vitamin K2 supplier partner. The company will transition the seven products in its line currently featuring Vitamin K2 to MenaQ7® PRO, a unique line extension available only to Ortho Molecular.
For more than 25 years, Ortho Molecular Products has researched and manufactured high-quality, nutraceuticals sold exclusively to thousands of health care professionals across the US and in Canada.
“We are proud of our 25 year tradition of successfully combining evidence-based formulations and superior raw ingredients to develop efficacious supplements that noticeably enhance patient health,” says Aaron Bartz, President of Ortho Molecular Products, adding that MenaQ7® was chosen based on the significant data confirming its ability to help the body properly utilize calcium, supporting bone health while simultaneously protecting cardiovascular health. “This partnership with NattoPharma reinforces that commitment, allowing us to provide the practitioner community with the best quality, clinically validated Vitamin K2 as MK-7 available.”
“Ortho Molecular Products’ commitment to efficacy, uncompromising manufacturing and legendary customer service has established the company as a leader in the nutrition industry,” says Dan Rosenbaum, NattoPharma CEO. “NattoPharma is honored that this discerning brand recognizes that we are the leader in Vitamin K2 research and development, and that our MenaQ7 Vitamin K2 as MK-7 will allow their practitioner partners to deliver the best possible results for their patients.